Leukemia Clinical Trials in New York

Showing 1321-1340 of 1,542 trials

Irinotecan and Bevacizumab for Recurrent Ovarian Cancer

NCT01091259

The purpose of the study is to evaluate the efficacy and toxicity of irinotecan in the treatment of women with recurrent epithelial ovarian cancer or primary peritoneal cancer when combined with bevacizumab.

Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma

NYU Langone Health29 participantsStarted Mar 2010

New York, New York, United States • New York, New York, United States

COMPLETEDPhase 3< 1 mile

Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)

NCT00409188

The purpose of this study is to determine whether the cancer vaccine tecemotide (L-BLP25) in addition to best supportive care is effective in prolonging the lives of subjects with unresectable stage III non-small cell lung cancer, compared to best supportive care alone. A local ancillary (sub) study in European centers will evaluate the immune response in peripheral blood after tecemotide (L-BLP25) or placebo vaccination.

Non-small Cell Lung Cancer

EMD Serono1,513 participantsStarted Jan 2007

Fort Smith, Arkansas, United States • Anaheim, California, United States • Glendale, California, United States +287 more locations

Irinotecan and Bevacizumab for Recurrent Ovarian Cancer

Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)

Leukemia Trials in Other Cities

Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types

Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer

A Study Of Ranpirnase(Onconase®) To Pemetrexed Plus Carboplatin In Patients With Non-Squamous Non-Small Cell Lung Cancer

HIV/STI Prevention for Adolescents With Substance Use Disorders in Treatment

Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors

Assessment of Video Assisted Thoracoscopic Surgery (VATS) Versus Open Surgery for Patients Undergoing Lobectomy

Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML)

Use of a Video Decision Tool to Improve Informed Decision-Making in Hospitalized Patients Considering Palliative Radiation Therapy

Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance

Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer

Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer

Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma

S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML

A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment

A Study Of Combined C- MET Inhibitor And PAN-HER Inhibitor (PF-02341066 And PF-00299804) In Patients With Non- Small Cell Lung Cancer

Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer

Randomized Phase Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to Imatinib

Other Conditions in New York